Treatment and Adherence Strategies in Cutaneous T-Cell Lymphoma

Brad Haverkos, MD, discusses evolving management and treatment adherence strategies in cutaneous T-cell lymphoma.

Brad Haverkos, MD, discusses approaches for the management of mogamulizumab-associated rash in patients with cutaneous T-cell lymphoma.

Stefan K. Barta, MD, MS, discusses how to distinguish MAR from mycosis fungoides lesions in cutaneous T-cell lymphoma.

Brad Haverkos, MD, discusses how he utilizes mogamulizumab for cutaneous T-cell lymphoma and how to manage rashes associated with the treatment.

Stefan K. Barta, MD, MS, discusses the CTCL subtype mycosis fungoides, common adverse effects, and optimal treatment approaches.